About this trial
To achieve rapid, intelligent and accurate microbiological diagnosis and treatment for ICU pneumonia, an artificial neural network model for microbiological diagnosis is established, which depends on many clinical cases and machine deep learning from clinical experts' judgements according to species-specific rapid detection of pathogenic bacteria and other clinical parameter variables of patients.
Eligibility criteria
Qualifiers
aged ≥18 years;
agreed to obtain lower respiratory specimens for rapid testing of pathogenic bacteria;
all were enrolled by an experienced physician who dynamically determined that the microorganisms were in a colonised or infected state;
signed an informed consent form.
Disqualifiers
pregnant women;
lactating women;
patients who could not obtain lower respiratory specimens;
Trial design
Treatments tested in this trial
- establish an artificial neural network model